Must be incorporated in the USA Must have some revenue (any) Must demonstrate how your company will impact underrepresented ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as ... two major drug makers, Eli Lilly and Novartis, that could ...

NEW YORK (AP) — Wall Street is drifting between gains and losses Thursday as UnitedHealth Group’s stock plunges toward its ...

Employment in the U.S. life sciences sector hit a record high in 2024, and more job growth is expected in 2025.

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...

Drugs like Ozempic and Mounjaro are GLP-1-based medications, meaning they mimic gut hormones that help regulate appetite and blood sugar. In the process, they suppress hunger, slo ...

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund ... s efficacy is competitive with Eli Lilly, which will take time. We further reduced ...

Technology stocks held steadier following their sell-off from the day before after global heavyweight Taiwan ... in the United States rose 1.1%. Eli Lilly was another winner after the drugmaker ...

Patterson Companies ("Patterson" or the "Company"), a leading supplier of products and services to the dental and animal health end markets, successfully completed its acquisition by Patient Square ...

Meanwhile, Global markets experienced significant declines on Wednesday ... Shares of major pharmaceutical companies such as Pfizer, Eli Lilly, and Bristol-Myers Squibb fell by approximately 3% after ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric ...